24-10-2023 08:00 via wallstreet-online.de

Interim Report January-September 2023

GOTHENBURG, SWEDEN / ACCESSWIRE / October 24, 2023 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)Third quarter 2023 (July 1 - September 30) • Net sales amounted to SEK 146.6 million (96.8), corresponding to an increase of 51 percent in SEK and …
Weiterlesen »